IMAX And Bona Film Group Sign Three-Theatre Agreement In China Canada NewsWire
China's Largest Privately-Owned Media Film Distributor Expands IMAX Relationship; Deal Builds on Success of Parties' Film and Exhibition Partnership SHANGHAI , Nov.
Ocular Therapeutix (NASDAQ:OCUL), a biopharmaceutical company focused on
the development and commercialization of innovative therapies for
diseases and conditions of the eye, today announced financial results
for the third quarter ended September 30, 2014, and provided an update
on current business developments.
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company
focused on the development and commercialization of innovative therapies
for diseases and conditions of the eye, today announced top line results
for a Phase 2 clinical trial evaluating Sustained Release Dexamethasone
(OTX-DP) for treatment of allergic conjunctivitis.
By Barbara Kollmeyer, MarketWatch Strategist: 2,040 proving a tough barrier for the S&P 500
MADRID (MarketWatch) -- Stock futures eased back on Wednesday, indicating that Wall Street could struggle to log a sixth session of record highs for major indexes, with Europe stocks and oil prices dropping.
By Sean Carney
PRAGUE--Czech power company CEZ AS (BAACEZ.PR) said Wednesday that it doesn't expect power prices to rise in the foreseeable future and that it remains interested in regional acquisitions, but declined to comment on several possible deals in neighboring countries.
SAO PAULO--Private-equity firms Apax Partners LLP and Bain Capital LLC have joined forces and made a binding offer to buy PT Portugal from its Brazilian owner Oi SA (OIBR).
The offer values the assets at an enterprise value of 7.07 billion euros ($8.8 billion) on a cash and debt free basis, Oi said in a statement on Wednesday.
By Anora Mahmudova and Barbara Kollmeyer, MarketWatch Strategist: 2,040 proving a tough barrier for the S&P 500
NEW YORK (MarketWatch) -- U.S. stocks ended Wednesday's choppy session essentially flat, as the main indexes struggled to stay in record territory.
Clarifies Tender Offer Terms, Largely in Response to GFI Board Request BGC'S $5.25 Per Share All-Cash Offer is Clearly Superior to the Proposed CME Transaction
Shareholders Urged to Send a Strong Message by Promptly Tendering Their Shares NEW YORK , Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.